New approach promising against multiple sclerosis
Reuters - USA
... with the incurable disease multiple sclerosis, researchers said on Monday. Their small study showed that treatment with high doses of cyclophosphamide, ...
See all stories on this topic

HIGH-DOSE IMMUNOSUPPRESSANT DRUG, DISABILITY, MS PATIENTS
Newswise (press release) - USA
Multiple sclerosis (MS) is an inflammatory disease in which the protective coating covering nerve cells degenerates, presumably because of autoimmune causes ...
See all stories on this topic

Shares Of Acorda Therapeutics Jump On Positive Trial Results Of ...
RTT News - Williamsville,NY,USA
Acorda Therapeutics announced positive results from a second late-stage clinical trial of a drug called Fampridine-SR, which studied walking ability in ...
See all stories on this topic

---

High-Dose Cyclophosphamide Shows Promise for Aggressive MS
MedPage Today - Little Falls,NJ,USA
By Charles Bankhead, Staff Writer, MedPage Today BALTIMORE, June 9 -- Aggressive relapsing-remitting multiple sclerosis responded significantly to high-dose ...
See all stories on this topic

---

\Merck Serono's Rebif(R) Celebrates 10th Anniversary
PR Newswire UK (press release) - London,UK
With regulatory filing expected in 2009, cladribine tablets could potentially become the first oral therapy for MS. Merck Serono is also taking a leading ...
See all stories on this topic

Australia to enter the race to clone human embryo cells for stem ...
News-Medical.net - Sydney,Australia
The teams are seeking permission to use eggs left over from fertility treatments to clone human embryonic stem cells. Professor Richard Boyd the director of ...
See all stories on this topic

---

FTY720 Trial Continues Despite Death, UK
Drug manufacturer Novartis has reported that two people with MS taking the oral drug fingolimod (FTY720) in clinical trials experienced problems with infections, leading to a fatality in one case.

---

Sunshine may be nature's disease fighter

By Thomas H. Maugh II

Men lacking in vitamin D have more than double the normal risk of a heart attack, a study says, one of many suggesting the vitamin is crucial to good health.

---

Carers Can't Afford To Be Ill, UK
Carers across the country - who tirelessly devote their time, effort and energy to looking after a loved one - could be putting their own health at risk by ignoring symptoms or not finding the time to visit their own GP for help and advice, a survey has found.

---

Link Between Chronic Inflammation And Cancer Confirmed
According to scientists at the Massachussets Institute of Technology,chronic inflammation of the intestine or stomach has been linked to DNAdamage and thus increased cancer risk. These results were released onJune 2, 2008 in the Journal of Clinical Investigation(JCI).